Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer

被引：0
|
作者：
He, Yong [1 ]
机构：
[1] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 373卷 / 06期
关键词：
METFORMIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：578 / 578
页数：1
相关论文
共 50 条
  • [41] Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR-mutated non-small-cell lung cancer
    Cheema, P. K.
    Gomes, M.
    Banerji, S.
    Joubert, P.
    Leighl, N. B.
    Melosky, B.
    Sheffield, B. S.
    Stockley, T.
    Ionescu, D. N.
    CURRENT ONCOLOGY, 2020, 27 (06) : 321 - 329
  • [42] Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib
    Robinson, Nathaniel D.
    Canavan, Maureen E.
    Zhan, Peter L.
    Udelsman, Brooks, V
    Pathak, Ranjan
    Boffa, Daniel J.
    Goldberg, Sarah B.
    CLINICAL LUNG CANCER, 2025, 26 (01)
  • [43] Cost-Effectiveness Analysis of Different Sequences of Osimertinib Administration for EGFR-Mutated Non-Small-Cell Lung Cancer
    Li, W.
    Qian, L.
    Li, W.
    Chen, X.
    He, H.
    Tian, H.
    Zhao, Y.
    Wang, X.
    Cui, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1067 - S1067
  • [44] Plain language summary of PAPILLON: amivantamab plus chemotherapy in untreated EGFR-mutated non-small-cell lung cancer
    Sabari, Joshua K.
    Girard, Nicolas
    Mansfield, Aaron S.
    Sanborn, Rachel E.
    Agrawal, Trishala
    Zhou, Caicun
    Park, Keunchil
    FUTURE ONCOLOGY, 2024, 20 (32) : 2409 - 2421
  • [45] Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
    Maemondo, Makoto
    Inoue, Akira
    Kobayashi, Kunihiko
    Sugawara, Shunichi
    Oizumi, Satoshi
    Isobe, Hiroshi
    Gemma, Akihiko
    Harada, Masao
    Yoshizawa, Hirohisa
    Kinoshita, Ichiro
    Fujita, Yuka
    Okinaga, Shoji
    Hirano, Haruto
    Yoshimori, Kozo
    Harada, Toshiyuki
    Ogura, Takashi
    Ando, Masahiro
    Miyazawa, Hitoshi
    Tanaka, Tomoaki
    Saijo, Yasuo
    Hagiwara, Koichi
    Morita, Satoshi
    Nukiwa, Toshihiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2380 - 2388
  • [46] Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
    Mehlman, Camille
    Cadranel, Jacques
    Rousseau-Bussac, Gaelle
    Lacave, Roger
    Pujals, Anais
    Girard, Nicolas
    Callens, Celine
    Gounant, Valerie
    Theou-Anton, Nathalie
    Friard, Sylvie
    Tredaniel, Jean
    Blons, Helene
    Dujon, Cecile
    Duchemann, Boris
    Schischmanoff, Pierre Olivier
    Chinet, Thierry
    Leprieur, Etienne Giroux
    LUNG CANCER, 2019, 137 : 149 - 156
  • [47] Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers
    Rangachari, Deepa
    Yamaguchi, Norihiro
    VanderLaan, Paul A.
    Folch, Erik
    Mahadevan, Anand
    Floyd, Scott R.
    Uhlmann, Erik J.
    Wong, Eric T.
    Dahlberg, Suzanne E.
    Huberman, Mark S.
    Costa, Daniel B.
    LUNG CANCER, 2015, 88 (01) : 108 - 111
  • [48] Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease
    McLean, Luke S.
    Faisal, Wasek
    Parakh, Sagun
    Kao, Steven C.
    Lewis, Craig R.
    Chin, Melvin T.
    Voskoboynik, Mark
    Itchins, Malinda J.
    Jennens, Ross R.
    Broad, Adam R.
    Morris, Tessa A.
    Solomon, Benjamin J.
    JCO PRECISION ONCOLOGY, 2021, 5 : 561 - 568
  • [49] Tiger-3: A Phase 3 Randomized Study of Rociletinib Vs Chemotherapy in EGFR-mutated Non-small Cell Lung Cancer (NSCLC)
    Yang, J. C.
    Reckamp, K.
    Kim, Y.
    Novello, S.
    Smit, E.
    Lee, J.
    Su, W.
    Akerley, W.
    Blakely, C.
    Bazhenova, L.
    Chiari, R.
    Hsia, T.
    Golsorkhi, T.
    Despain, D.
    Shih, D.
    Rolfe, L.
    Popat, S.
    Wakelee, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2397 - S2397
  • [50] Aumolertinib as adjuvant therapy in postoperative EGFR-mutated non-small cell lung cancer
    Zhang, Q.
    He, C.
    He, T.
    Wang, Y.
    Lv, W.
    Hu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S73 - S73
12345